Dr Harris of Armour described Dr Rotblat as "a valuable ally at the moment" and recorded that "I am now obliged to report Dr Whitmore's patient who sero-converted following treatment with Factorate HT Y69402 to her as Dr Whitmore has confirmed that the patient remains HTLV-III positive."
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Peter A Harris
Dr Frances Rotblat